Sickle cell patients deserve controlled recommendations.
Strauss
Ronald G
RG
D000755:Anemia, Sickle Cell / Q000628:therapy*; D015415:Biomarkers; D001787:Blood Group Incompatibility; D001788:Blood Grouping and Crossmatching; D015986:Confounding Factors, Epidemiologic; D018849:Controlled Clinical Trials as Topic / Q000592:standards*; D004311:Double-Blind Method; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D006801:Humans; D007114:Immunization; D007519:Isoantigens / Q000276:immunology; D008913:Minority Groups; D015337:Multicenter Studies as Topic / Q000592:standards*; D018579:Patient Selection; D017410:Practice Guidelines as Topic / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design / Q000592:standards*
D015415:Biomarkers; D007519:Isoantigens